Over 100 key leaders and influencers in inhaled and respiratory therapy formulation representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions.

Over 20 presentations and case studies focusing on the key issues in formulating inhaled therapies for both respiratory and alternative therapeutic areas, as well as on the development of novel inhalation devices to improve patient adherence and technique.